Latest Organ transplant Stories

Some patients with advanced heart failure caused by cardiomyopathy, the deterioration of function of the heart muscle, are getting a new lease on life thanks to an innovative treatment program at Jewish Hospital, a part of KentuckyOne Health, and the University of Louisville. Led by Emma Birks, M.D., Ph.D., FRCP, director of the Jewish Hospital Heart Failure, Transplant and Mechanical Support Program, the program treats advanced heart failure patients who have left ventricular assist...

Organ transplant patients usually spend a lifetime on expensive and often dangerous anti-rejection drugs. But experts have announced that such drugs may not even be needed in the future, thanks to a new study that suggests patients receiving an organ that is less than a perfect match can be protected against rejection by a second transplant of the donor’s imperfectly matched stem cells. The study is being hailed as a game-changer for transplantation. Experts announced the success of...

WINSTON-SALEM, N.C., March 8, 2012 /PRNewswire/ -- Tengion, Inc. (NASDAQ: TNGN), a leader in regenerative medicine, today announced that A. Brian Davis, Chief Financial Officer and Vice President, Finance of Tengion, will present at the upcoming 24th Annual ROTH Investor Conference on Tuesday, March 13, 2012, at 3:00 p.m. PDT in Laguna Niguel, California. A live audio webcast of the presentation can be accessed at http://wsw.com/webcast/roth26/tngn/ or under "Calendar of Events" in...

First-of-its-kind study where donor, recipient are not related or immunologically matched CHICAGO, March 7, 2012 /PRNewswire-USNewswire/ -- New ongoing research published today in the journal Science Translational Medicine suggests organ transplant recipients may not require anti-rejection medication in the future thanks to the power of stem cells, which may prove to be able to be manipulated in mismatched kidney donor and recipient pairs to allow for successful transplantation...

First patient successfully receives donor heart. Second patient on Freedom Driver. NORFOLK, Va., March 6, 2012 /PRNewswire-USNewswire/ -- Living without a heart. What was once only a far off concept has now become a reality for advanced heart failure patients in need of more time to await a heart transplant. (Photo: http://photos.prnewswire.com/prnh/20120306/DC65557) Physicians at Sentara Heart Hospital have begun offering the Total Artificial Heart (TAH) as the latest...

The New Force in Accountable Care Software Set for Unprecedented Growth in 2012 Omaha, NE (PRWEB) March 04, 2012 Building on the heritage of the powerful OTTR™ brand, HKS Medical Information Systems announced this week it would officially change the Company’s name to OTTR, Inc. doing business as OTTR™ Chronic Care Solutions. "Brand recognition is critical in a competitive market. Since the acquisition and recapitalization of HKS, we’ve been visiting customers and they always...

There is good news for the 27,000 plus people around the world who donate a kidney each year. A study which followed living kidney donors for 10 years found that they were at no greater risk for heart disease than the healthy general population. Led by Dr. Amit Garg, a researcher at Lawson Health Research Institute and nephrologist at London Health Sciences Centre, the results provide important safety reassurances to donors, their recipients and health care professionals. In the general...

Research: Cardiovascular disease in kidney donors: Matched cohort study Living kidney donors are at no greater risk of heart disease than the healthy general population, finds a study published on bmj.com today. The results provide important safety reassurances to donors, their recipients and transplant professionals. In the general population, there is a strong link between reduced kidney function and an increased risk of cardiovascular disease. Given that people who donate a kidney...

Doctors Estimate up to 10 Patients a Year at Allegheny Could Benefit from the Total Artificial Heart as a Bridge to Transplant Tucson, Ariz. (PRWEB) March 01, 2012 SynCardia Systems, Inc., manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Allegheny General Hospital (AGH) performed its first implant of the SynCardia temporary Total Artificial Heart on Feb. 17. “We are extremely proud to be the first...

Johns Hopkins research identifies factors in long-term transplant survival Heart transplant patients who receive new organs before the age of 55 and get them at hospitals that perform at least nine heart transplants a year are significantly more likely than other people to survive at least 10 years after their operations, new Johns Hopkins research suggests. Examining data from the more than 22,000 American adults who got new hearts between 1987 and 1999, researchers found that roughly...